FoundationOne CDx (F1CDx)
FDA premarket approval P170019/S003 · decided 2018-10-11
Approval details
- PMA number
- P170019
- Supplement
- S003
- Supplement type
- Real-Time Process
- Supplement reason
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
- Trade name
- FoundationOne CDx (F1CDx)
- Generic name
- Next generation sequencing oncology panel, somatic or germline variant detection system
- Applicant
- Foundation Medicine, Inc.
- Date received
- 2018-08-30
- Decision date
- 2018-10-11
- Days to decision
- 42 days
- Decision code
- APPR
- Product code
- PQP
- Advisory committee
- Pathology
- Expedited review
- No
- Location
- Boston, MA
- Statement
- Approval to further delineate manufacturing steps for F1CDx.
Class III intelligence, same tools
PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.